1.
Yukio NAKAMURA, Takako SUZUKI, Hideshi YAMAZAKI, Hiroyuki KATO. Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis. Archives of Rheumatology [Internet]. 2018 Jun. 30 [cited 2025 Oct. 3];33(2):154-9. Available from: http://anadolupsikiyatri.net/index.php/pub/article/view/927